FDA Public Health Advisory

Symbyax (A combination of Olanzapine and fluoxetine hydrochloride) is an antidepressant and was approved in Dec, 2003. It is most often prescribed for the treatment of bipolar disorder.

In October 2004 the FDA approved the following for inclusion on a "black box" warning for the Symbyax label:

"Antidepressants increase the risk of suicidal thinking and behavior (suicidality) in children and adolescents with MDD and other psychiatric disorders."

Possible Symbyax Side Effects Lawsuit

If you or a family member have taken Symbyax and have experienced worsening depression or suicidal thoughts or behavior, you may be entitled to compensation.

Register your Symbyax Complaint with a Lawyer

If you feel you qualify for damages or remedies that might be awarded in a possible Symbyax lawsuit or class action, please fill in our form on the right to submit your complaint.

Reader Comments

Posted by

I stopped breathing in bed. I had something I would describe as a seizure. I ended up locked up in the hospital. Lost college credit. Housing crisis. Legal problems. Distrust with doctors. And more.

Posted by

My wife suffered from Bipolar disease and attempted suicide 4 times this year, and after each attempt she was only kept in the hospital 2 or 3 days, and was sent home with a different anti depressant each time. after her last attempt, she came home after 3 days in the hospital, and 2 days later I came home to find she hung herself.

Add Your Comment on This Issue

Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment:
Request Legal Help